Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
rMj Services
Ashburn or Vienna, Virginia, United Statesli-public.fmcsa.dot.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company's lead candidate, RMJH-111b, is a novel magnesium-based drug formulated with proprietary inverted micellar nanodroplets to improve intestinal absorption and cellular delivery. Early clinical studies have demonstrated safety and efficacy in lowering blood pressure in hypertensive adults without the gastrointestinal side effects typical of oral magnesium therapy[2][3].
- Therapeutic areas
- Metabolic DisordersCardiovascular
- Modalities
- Small moleculeNanoparticle
- Industry
- Biotech
Beyond the preview
Go deeper on rMj Services.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rMj Services.